Last Updated: June 18, 2026

DEXTROSE 50% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dextrose 50% In Plastic Container patents expire, and when can generic versions of Dextrose 50% In Plastic Container launch?

Dextrose 50% In Plastic Container is a drug marketed by Baxter Hlthcare, Icu Medical Inc, and Otsuka Icu Medcl. and is included in four NDAs.

The generic ingredient in DEXTROSE 50% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextrose profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DEXTROSE 50% IN PLASTIC CONTAINER?
  • What are the global sales for DEXTROSE 50% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for DEXTROSE 50% IN PLASTIC CONTAINER?
Summary for DEXTROSE 50% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 50% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 018563-001 Mar 23, 1982 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-001 Jul 2, 1991 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Icu Medical Inc DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019894-001 Dec 26, 1989 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.